Advertisement
Canadian Journal of Cardiology

Sleep-Disordered Breathing and Cardiac Arrhythmias

Published:April 29, 2015DOI:https://doi.org/10.1016/j.cjca.2015.04.022

      Abstract

      Over the past few years sleep-disordered breathing has been identified as an important factor in arrhythmogenesis and a potential target of therapy to prevent cardiac arrhythmias in selected patients. In this review we highlight the role of obstructive sleep apnea and Cheyne-Stokes respiration in the pathophysiology of arrhythmias, address their clinical effect in supraventricular and ventricular tachyarrhythmias, and in conduction disturbances, and address the role of current treatment options for sleep-disordered breathing in the primary and secondary prevention of arrhythmic events.

      Résumé

      Au cours des dernières années, il a été reconnu que les troubles respiratoires du sommeil sont un facteur important de l’arythmogenèse et une cible potentielle de traitement pour prévenir les arythmies cardiaques chez certains patients. Dans cette revue, nous soulignons le rôle de l’apnée obstructive du sommeil et de la respiration de Cheyne-Stokes dans la physiopathologie des arythmies, abordons leurs conséquences cliniques dans les tachyarythmies supraventriculaires et ventriculaires, et dans les troubles de conduction, puis abordons le rôle des options actuelles de traitements contre les troubles respiratoires du sommeil dans la prévention primaire et secondaire des événements arythmiques.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Echt D.
        • Liebson P.
        • Mitchell L.B.
        • et al.
        Mortality and morbidity in patients receiving ecainide, flecainide, or placebo. The Cardiac Arrhythia Suppression Trial.
        N Engl J Med. 1991; 324: 781-788
        • Singh J.
        • Hall W.
        • McNitt S.
        • et al.
        Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
        J Am Coll Cardiol. 2005; 46: 1712-1720
        • Moss A.J.
        • Schuger C.
        • Beck C.A.
        • et al.
        Reduction in inappropriate therapy and mortality through ICD programming.
        N Engl J Med. 2012; 367: 2275-2283
        • Brignole M.
        • Auricchio A.
        • Baron-Esquivias G.
        • et al.
        2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association.
        Eur Heart J. 2013; 34: 2281-2329
        • Wolf P.
        • Dawber T.
        • Thomas H.
        • Kannel W.
        Epidemiologic assessment of chronic atrial fibrillation and the risk of stroke: the Framingham study.
        Neurology. 1978; 28: 973-977
        • Kannel W.
        • Wolf P.
        • Benjamin D.
        • Levy D.
        Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates.
        Am J Cardiol. 1998; 82: 2N-9N
        • Lown B.
        • Tykocinski M.
        • Garfein A.
        • Brooks P.
        Sleep and ventricular premature beats.
        Circulation. 1973; 48: 691-701
        • Trinder J.
        • Kleiman J.A.
        • Carrington M.
        Autonomic activity during human sleep as a function of time and sleep stage.
        J Sleep Res. 2001; 10: 253-264
        • Furukawa Y.
        • Shimizu H.
        • Hiromoto K.
        • Kanemori T.
        Circadian variation of beat-to-beat QT interval variability in patients with prior myocardial infarction and the effect of β-blocker therapy.
        Pacing Clin Electrophysiol. 2006; 29: 479-486
        • Jeyaraj D.
        • Haldar S.M.
        • Wan X.
        • et al.
        Circadian rhythms govern cardiac repolarization and arrhythmogenesis.
        Nature. 2012; 483: 96-99
        • Solin P.
        • Kaye D.
        • Little P.
        • et al.
        Impact of sleep apnoea on sympathetic nervous system activity in heart failure.
        Chest. 2003; 123: 1119-1126
        • Stevenson I.H.
        • Roberts-Thomson K.C.
        • Kistler P.M.
        • et al.
        Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea.
        Heart Rhythm. 2010; 7: 1263-1270
        • Linz D.
        • Hohl M.
        • Nickel A.
        • et al.
        Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea.
        Hypertension. 2013; 62: 767-774
        • Ghias M.
        • Scherlag B.J.
        • Lu Z.
        • et al.
        The role of ganglionated plexi in apnea-related atrial fibrillation.
        J Am Coll Cardiol. 2009; 54: 2075-2083
        • Koshino Y.
        • Villarraga H.R.
        • Orban M.
        • et al.
        Changes in left and right ventricular mechanics during the Mueller maneuver in healthy adults.
        Circ Cardiovasc Imaging. 2010; 3: 282-289
        • Iwasaki Y.
        • Shi Y.
        • Benito B.
        • et al.
        Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea.
        Heart Rhythm. 2012; 9: 1409-1416.e1
        • Linz D.
        • Schotten U.
        • Neuberger H.R.
        • Böhm M.
        • Wirth K.
        Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation.
        Heart Rhythm. 2011; 8: 1436-1443
        • Linz D.
        • Mahfoud F.
        • Schotten U.
        • et al.
        Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea.
        Hypertension. 2012; 60: 172-178
        • Fletcher F.
        Effect of hypoxia on sympathetic activity and blood pressure.
        Respir Physiol. 2000; 119: 189-197
        • Kraiczi H.
        • Hedner J.
        • Peker Y.
        • Carlson J.
        Increased vasoconstrictor sensitivity in obstructive sleep apnea.
        J Appl Physiol. 2000; 89: 493-498
        • Oliveira W.
        • Campos O.
        • Cintra F.
        • et al.
        Left atrial volume and function in patients with obstructive sleep apnea assessed by real-time three dimensional echocardiography.
        J Am Soc Echocardiogr. 2008; 21: 1355-1361
        • Bitter T.
        • Horstkotte D.
        • Oldenburg O.
        Sleep disordered breathing and cardiac arrhythmias: mechanisms, interactions, and clinical relevance.
        Dtsch Med Wochenschr. 2011; 136 ([in German]): 431-435
        • Iwasaki Y.K.
        • Kato T.
        • Xiong F.
        • et al.
        Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model.
        J Am Coll Cardiol. 2014; 64: 2013-2023
        • Pratt-Ubunama M.
        • Nishizaka M.
        • Boedefeld R.
        • et al.
        Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.
        Chest. 2007; 131: 453-459
        • Moller D.
        • Lind P.
        • Strunge B.
        • Pedersen E.
        Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea.
        Am J Hypertens. 2003; 16: 274-280
        • Dimitri H.
        • Ng M.
        • Brooks A.G.
        • et al.
        Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation.
        Heart Rhythm. 2012; 9: 321-327
        • Altekin R.
        • Yanikoglu A.
        • Karakas M.
        • et al.
        Assessment of left atrial dysfunction in obstructive sleep apnea patients with the two dimensional speckle-tracking echocardiography.
        Clin Res Cardiol. 2012; 101: 403-413
        • Shamsuzzaman A.S.
        • Winnicki M.
        • Lanfranchi P.
        • et al.
        Elevated C-reactive protein in patients with obstructive sleep apnea.
        Circulation. 2002; 105: 2462-2464
        • Schmalgemeier H.
        • Bitter T.
        • Dimitriadis Z.
        • et al.
        Severe central sleep apnea / Cheyne-Stokes respiration is associated with elevated C-reactive protein in heart failure patients.
        Eur J Heart Fail Suppl. 2011; 10: S71
        • Coumel P.
        • Rosengarten M.D.
        • Leclercq J.
        • Attuel P.
        Role of sympathetic nervous system in non-ischaemic ventricular arrhythmias.
        Br Heart J. 1982; 47: 137-147
        • Shepard J.W.
        • Garrison M.W.
        • Grither D.A.
        • Dolan G.F.
        Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea.
        Chest. 1985; 88: 335-340
        • Bradley T.D.
        • Hall M.J.
        • Ando S.
        • Floras J.S.
        Hemodynamic effects of simulated obstructive sleep apnea in humans with and without heart failure.
        Chest. 2001; 119: 1827-1835
        • Rossi V.A.
        • Stoewhas A.
        • Camen G.
        • et al.
        The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial.
        Eur Heart J. 2012; 33: 2206-2212
        • Barta K.
        • Szabo K.
        • Kun C.
        • et al.
        The effect of sleep apnea on QT interval, QT dispersion, and arrhythmias.
        Clin Cardiol. 2010; 33: E35-E39
        • Roche F.
        • Gaspoz J.M.
        • Court-Fortune I.
        • et al.
        Alteration of QT rate dependance reflects cardiac autonomic imbalance in patients with obstructive sleep apna syndrome.
        Pacing Clin Electrophysiol. 2003; 26: 1446-1453
        • Takasugi N.
        • Nishigaki K.
        • Kubota T.
        • et al.
        Sleep apnoea induces cardiac electrical instability assessed by T-wave alternans in patients with congestive heart failure.
        Eur J Heart Fail. 2009; 11: 1063-1070
        • Voigt L.
        • Hag S.
        • Mitre C.
        • Lombardo G.
        • Kassotis J.
        Effect of obstructive sleep apnea on QT dispersion: a potential mechanism of sudden cardiac death.
        Cardiology. 2011; 118: 68-73
        • Guilleminault C.
        • Connolly S.
        • Winkle R.
        • Melvin K.
        • Tilkian A.
        Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24h electrocardiography as a screening technique.
        Lancet. 1984; 1: 126-131
        • Mehra R.
        • Stone K.
        • Varosy P.
        • et al.
        Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men.
        Arch Intern Med. 2009; 169: 1147-1155
        • Namtvedt S.K.
        • Randby A.
        • Einvik G.
        Cardiac arrhythmias in obstructive sleep apnea (from the Akershus Sleep Apnea Project).
        Am J Cardiol. 2011; 108: 1141-1146
        • Cintra F.D.
        • Leite R.P.
        • Storti L.J.
        • et al.
        Sleep apnea and nocturnal cardiac arrhythmia: a populational study.
        Arq Bras Cardiol. 2014; 103: 368-374
        • Bitter T.
        • Langer C.
        • Vogt J.
        • et al.
        Sleep-disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function.
        Dtsch Arztebl Int. 2009; 106: 164-170
        • Stevenson I.H.
        • Teichtahl H.
        • Cunnington D.
        • et al.
        Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function.
        Eur Heart J. 2008; 29: 1662-1669
        • Bazan V.
        • Grau N.
        • Valles E.
        • et al.
        Obstructive sleep apnea in patients with typical atrial flutter: prevalence and impact on arrhythmia control outcome.
        Chest. 2013; 143: 1277-1283
        • Abed H.S.
        • Wittert G.A.
        • Leong D.P.
        • et al.
        Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.
        JAMA. 2013; 310: 2050-2060
        • Grimm W.
        • Becker H.F.
        Obesity, sleep apnea syndrome, and rhythmogenic risk.
        Herz. 2006; 31 ([quiz: 219]): 213-218
        • Barbe F.
        • Duran-Cantolla J.
        • Capote F.
        • et al.
        Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea.
        Am J Respir Crit Care Med. 2010; 181: 718-726
        • Gami A.
        • Hodge D.
        • Herges R.
        • et al.
        Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.
        J Am Coll Cardiol. 2007; 49: 565-571
        • Pedrosa R.P.
        • Drager L.F.
        • Genta P.R.
        • et al.
        Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy.
        Chest. 2010; 137: 1078-1084
        • Bixler E.
        • Vgontzas A.
        • Lin M.
        • et al.
        Excessice daytime sleepiness in a general population sample: the role of sleep apnea, age, diabetes and depression.
        J Clin Endocrinol Metab. 2005; 90: 4510-4515
        • Fong S.Y.
        • Ho C.K.
        • Wing Y.K.
        Comparing MSLT and ESS in the measurement of excessive daytime sleepiness in obstructive sleep apnoea syndrome B.
        J Psychosom Res. 2005; 58: 55-60
        • Albuquerque F.N.
        • Calvin A.D.
        • Kuniyoshi F.H.
        • et al.
        Sleep-disordered breathing and excessive daytime sleepiness in patients with atrial fibrillation.
        Chest. 2013; 141: 967-973
        • Szymanski F.
        • Filipiak K.
        • Karpinski G.
        • Platek A.
        • Opolski G.
        Occurrence of poor sleep quality in atrial fibrillation patients according to the EHRA score.
        Acta Cardiol. 2014; 69: 291-296
        • Monahan K.
        • Brewster J.
        • Wang L.
        • et al.
        Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter.
        Am J Cardiol. 2012; 110: 369-372
        • Kanagala R.
        • Murali N.
        • Friedman P.
        • et al.
        Obstructive sleep apnea and the recurrence of atrial fibrillation.
        Circulation. 2003; 107: 2589-2594
        • Bitter T.
        • Olker G.N.
        • Urgen J.
        • et al.
        Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: the independent role of sleep-disordered breathing.
        J Cardiovasc Electrophysiol. 2011; 23: 18-25
        • Naruse Y.
        Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy.
        Heart Rhythm. 2013; 10: 331-337
        • Fein A.S.
        • Shivillkin A.
        • Shah D.
        • et al.
        Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation.
        J Am Coll Cardiol. 2013; 62: 300-305
        • Ng C.
        • Liu T.
        • Shehata M.
        • et al.
        Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation.
        Am J Cardiol. 2011; 108: 47-51
        • Lissel C.
        • Hennigs S.
        • Hoffmann-Castendiek B.
        • et al.
        Effect of restoring sinus rhythm on sleep apnea in patients with atrial fibrillation or flutter.
        Am J Cardiol. 2008; 102: 709-711
        • Fox H.
        • Bitter T.
        • Horstkotte D.
        • Oldenburg O.
        Cardioversion of atrial fibrillation or atrial flutter decisively improves severity and type of sleep disordered breathing.
        Eur Heart J. 2014; 35 (abstract 427): 427
        • McNicholas W.T.
        Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome.
        Am J Physiol Regul Integr Comp Physiol. 2007; 293: R1666-R1670
        • Hadid C.
        Sustained ventricular tachycardia in structural heart disease.
        Cardiol J. 2015; 22: 12-24
        • Arntz H.
        • Willich S.
        • Schreiber C.
        • et al.
        Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24 061 consecutive cases.
        Eur Heart J. 2000; 21: 315-320
        • Gami A.S.
        • Howard D.E.
        • Olson E.J.
        • Somers V.K.
        Day-night pattern of sudden death in obstructive sleep apnea.
        N Engl J Med. 2005; 352: 1206-1214
        • Gami A.S.
        • Olson E.J.
        • Shen W.K.
        • et al.
        Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults.
        J Am Coll Cardiol. 2013; 62: 610-616
        • Macedo P.
        • Brugada J.
        • Leinveber P.
        • et al.
        Sleep-disordered breathing in patients with the Brugada syndrome.
        Am J Cardiol. 2011; 107: 709-713
        • Grimm W.
        • Apelt S.
        • Timmesfeld N.
        • Koehler U.
        Sleep-disordered breathing in patients with implantable cardioverter-defibrillator.
        Europace. 2013; 15: 515-522
        • Prinz C.
        • Bitter T.
        • Oldenburg O.
        • Horstkotte D.
        • Faber L.
        Incidence of sleep-disordered breathing in patients with hypertrophic cardiomyopathy.
        Congest Heart Fail. 2011; 17: 19-24
        • McMurray J.J.
        • Adamopopoulos S.
        • Anker S.D.
        • et al.
        ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012.
        Eur Heart J. 2012; 33: 1787-1847
        • Oldenburg O.
        • Lamp B.
        • Faber L.
        • et al.
        Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients.
        Eur J Heart Fail. 2007; 9: 251-257
        • Jilek C.
        • Krenn M.
        • Sebah D.
        • et al.
        Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study.
        Eur J Heart Fail. 2011; 13: 68-75
        • Lanfranchi P.
        • Somers V.
        • Braghiroli A.
        • et al.
        Central sleep apnoea in left ventricular dysfunction: prevalence and implications for arrhythmic risk.
        Circulation. 2003; 107: 727-732
        • Fichter J.
        • Bauer D.
        • Arampatzis S.
        • Fries R.
        Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable implantable cardioverter-defibrillator.
        Chest. 2002; 122: 558-561
        • Tomaello L.
        • Zanolla L.
        • Vassanelli C.
        • LoCoscio V.
        • Ferrari M.
        Sleep disordered breathing is associated with appropriate implantable cardioverter defibrillator therapies in congestive heart failure patients.
        Clin Cardiol. 2010; 33: E27-E30
        • Bitter T.
        • Westerheide N.
        • Prinz C.
        • et al.
        Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure.
        Eur Heart J. 2011; 32: 61-74
        • Kreuz J.
        • Skowasch D.
        • Horlbeck F.
        • et al.
        Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
        Am J Cardiol. 2013; 111: 1319-1323
        • Daubert D.
        • Zareba W.
        • Cannom D.
        • et al.
        Inappropriate implantable cardioverter-defibrillator shocks in MADIT II.
        J Am Coll Cardiol. 2008; 51: 1357-1365
        • Bitter T.
        • Gutleben K.
        • Nölker G.
        • et al.
        Sleep-disordered breathing and inappropriate defibrillator shocks in chronic heart failure.
        Herzschrittmacherther Elektrophysiol. 2014; 25: 198-205
        • Bitter T.
        • Fox H.
        • Dimitriadis Z.
        • et al.
        Circadian variation of defibrillator shocks in patients with chronic heart failure: the impact of Cheyne-Stokes respiration and obstructive sleep apnea.
        Int J Cardiol. 2014; 176: 1033-1035
        • Abe H.
        • Takahashi M.
        • Yaegashi H.
        • et al.
        Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients.
        Heart Vessel. 2010; 25: 63-69
        • Ryan C.M.
        • Usui K.
        • Floras J.S.
        • Bradley T.D.
        Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea.
        Thorax. 2005; 60: 781-785
        • Javaheri S.
        Effects of continuous positive airway pressure on sleep apnoea and ventricular irritability in patients with heart failure.
        Circulation. 2000; 101: 392-397
        • Bitter T.
        • Gutleben K.J.
        • Nölker G.
        • et al.
        Treatment of Cheyne-Stokes respiration reduces arrhythmic events in chronic heart failure.
        J Cardiovasc Electrophysiol. 2013; 24: 1132-1140
        • Guilleminault C.
        • Connolly S.
        • Winkle R.
        Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnoea syndrome.
        Am J Cardiol. 1983; 52: 490-494
        • Koehler U.
        • Fus E.
        • Grimm W.
        • et al.
        Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment.
        Eur Respir J. 1998; 11: 434-439
        • Becker H.F.
        • Koehler U.
        • Stammnitz A.
        • Peter J.H.
        Heart block in patients with sleep apnoea.
        Thorax. 1998; 53: 29-33
        • Miller W.
        Cardiac arrhythmias and conduction disturbances in the sleep apnea syndrome. Prevalence and significance.
        Am J Med. 1982; 73: 317-321
        • Becker H.
        • Brandenburg U.
        • Peter J.H.
        • Von Wichert P.
        Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure.
        Am J Respir Crit Care Med. 1995; 151: 215-218
        • Grimm W.
        • Koehler U.
        • Fus E.
        • et al.
        Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy.
        Am J Cardiol. 2000; 86: 688-692
        • Simantirakis E.
        • Schiza S.
        • Marketou M.
        • et al.
        Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder.
        Eur Heart J. 2004; 25: 1070-1076
        • Mehra R.
        • Benjamin E.J.
        • Shahar E.
        • et al.
        Association of nocturnal arrhythmias with sleep-disordered breathing. The Sleep Heart Health Study.
        Am J Respir Crit Care Med. 2006; 173: 910-916